Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-30 18:20:53 - browse：7981

The corporate offices of Massachusetts General Brigham hospitals in Assembly Square in Somerville. Lane Turner/Globe Staff

The severing of ties between two of Boston’s biggest health care giants has placed one of the nation’s largest health care systems in the position of figuring out how, exactly, to fill a new hole in its oncology services, at a time when cancer care is changing rapidly.

Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration. The split will take a few years to play out — Dana-Farber and Brigham and Women’s have a contract into 2028 — but has shaken patients and physicians.

Anne Klibanski, chief executive of Brigham and Women’s parent organization, Mass General Brigham, placed the blame on Dana-Farber executives. The two parties had been in discussions about extending their contract for months when the split was announced. “The decision was made by the Farber. It was announced. Now, we just have to plan forward,” she said. Klibanski shared her views on the split at a meeting with Boston Globe opinion editors on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Medical students need to learn the potent medicine of empathy

WSS

Explaining an after

Medicare proceeds with plan to claw back hospital funds

Why we need mandatory labeling of GMO products

Prime Medicine says its gene editing passes test in monkeys

Clinicians often fail to acknowledge the pain caused by long Covid

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Wikipedia

Wikipedia

focus

Wildfire smoke exposes gaps in outdoor worker protections

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

United colonoscopy coverage change 'may cost lives,' doctors say

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Sports medicine is finally prioritizing gender equality

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Duchenne breakthrough therapy leaves behind pioneering families

Guardant Health colon cancer test endorsed by FDA advisory panel

How to save PrEP access — and even expand it

Achieving telehealth equity for people with hearing loss

knowledge

Gene therapy’s promise and the high cost of hope

Brain injuries and the importance of a second opinion

Prime Medicine says its gene editing passes test in monkeys

Readout LOUD podcast: ESMO highlights & Roivant's big deal

What is microchimerism and how does it affect maternal health?

The world needs the new pandemic treaty

knowledge

entertainment

hotspot

explore